Novartis

Latest stories

5h
Reuters
Anacor reveals receiving rival bid before Pfizer deal: filingsaid they had expected Anacor to be acquired by Allergan, which has a stronger
Anacor reveals receiving rival bid before Pfizer deal: filing
Reuters / Posted 5 hours ago
said they had expected Anacor to be acquired by Allergan, which has a stronger presence in the dermatology market, or by Novartis AG's (NOVN.S) Sandoz unit, which sells Anacor's toenail fungus drug in the United States. Some also said that with... Read more
6h
MedCity News
MIT invents machine for fast pharma prototype-makingus with a lot of opportunities that are very powerful,” said Jamison. His lab a
MIT invents machine for fast pharma prototype-making
MedCity News / Posted 6 hours ago
us with a lot of opportunities that are very powerful,” said Jamison. His lab and Myerson’s also are collaborating with the Novartis-MIT Center for Continuous Manufacturing, which is funded by the pharmaceutical company Novartis. The prototype... Read more
15h
Business Wire
Model N to Attend Craig-Hallum Institutional Investor Conferencetechnology and manufacturing across more than 100 countries including Johnson &
Model N to Attend Craig-Hallum Institutional Investor Conference
Business Wire / Posted 15 hours ago
technology and manufacturing across more than 100 countries including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Atmel and Fairchild. For more information, visit www.modeln.com. Model N® is the registered trademark of Model N,... Read more
15h
The Economic Times
Amazing rally! Sensex surges 485 points; Nifty50 at 8,069Union Bank, Jet Airways, India Cements, Tata Chemicals, JP Infratech, Mphasis,
Amazing rally! Sensex surges 485 points; Nifty50 at 8,069
The Economic Times / Posted 15 hours ago
Union Bank, Jet Airways, India Cements, Tata Chemicals, JP Infratech, Mphasis, Natco Pharma, Neyveli Lignite, Novartis, among others, are the BSE-listed companies that will disclose their March quarter numbers through the day. The... Read more
15h
The Huffington Post
Key Democrat Incensed Over 'Intimidation' For High Drug Pricesthat the United States government vehemently opposed Colombia's plan to allow a
Key Democrat Incensed Over 'Intimidation' For High Drug Prices
The Huffington Post / Posted 15 hours ago
that the United States government vehemently opposed Colombia's plan to allow a generic copy of the cancer drug Gleevec. Novartis, the Swiss pharmaceutical giant that has a monopoly on the drug in Colombia, charges more than double the nation's... Read more
1d
Daily Record
Novartis, Laddey, Clark & Ryan making Morris County business newsNovartis employees help out at child care center EAST HANOVER: As part of the
Novartis, Laddey, Clark & Ryan making Morris County business news
Daily Record / Posted yesterday
Novartis employees help out at child care center EAST HANOVER: As part of the Novartis Group’s 20th annual Community Partnership Day, a group of employees spent a workday at Parsippany Child Day Care Center. Parsippany Child Day Care Center... Read more
1d
FOX Business
4 Safe Stocks With Dividend Yields Above 5%future growth prospects lies in its newly found revenue diversity. After comple
4 Safe Stocks With Dividend Yields Above 5%
FOX Business / Posted yesterday
future growth prospects lies in its newly found revenue diversity. After completing a three-part asset swap with Novartisin 2015, GSK now derives substantially more revenue from vaccines and a joint-venture in consumer healthcare with... Read more
4 related stories
1d
FOX Business
4 Safe Stocks With Dividend Yields Above 5%future growth prospects lies in its newly found revenue diversity. After comple
4 Safe Stocks With Dividend Yields Above 5%
FOX Business / Posted yesterday
future growth prospects lies in its newly found revenue diversity. After completing a three-part asset swap with Novartisin 2015, GSK now derives substantially more revenue from vaccines and a joint-venture in consumer healthcare with... Read more
4 related stories
1d
Reuters
Novartis willing to sell Roche stake without demanding premium - CEOZURICH Swiss drugmaker Novartis (NOVN.S) is ready to sell its near $14 billion
Novartis willing to sell Roche stake without demanding premium - CEO
Reuters / Posted yesterday
ZURICH Swiss drugmaker Novartis (NOVN.S) is ready to sell its near $14 billion stake in rival Roche (ROG.S) without demanding a premium, Chief Executive Joe Jimenez said on Wednesday. Novartis has been discussing options with banks for selling its... Read more
1d
Channel NewsAsia
Novartis willing to sell Roche stake without demanding premium - CEOZURICH: Swiss drugmaker Novartis is ready to sell its near US$14 billion stake
Novartis willing to sell Roche stake without demanding premium - CEO
Channel NewsAsia / Posted yesterday
ZURICH: Swiss drugmaker Novartis is ready to sell its near US$14 billion stake in rival Roche without demanding a premium, Chief Executive Joe Jimenez said on Wednesday. Novartis has been discussing options with banks for selling its Roche shares... Read more
2d
The Economic Times
Novartis India shares jump over 17% on buyback planat Rs 833 on the Bombay Stock Exchange. On May 18, the company had announced it
Novartis India shares jump over 17% on buyback plan
The Economic Times / Posted 2 days ago
at Rs 833 on the Bombay Stock Exchange. On May 18, the company had announced it would hold its board meeting on May 26. Novartis AG, the company's Switzerland-based parent, owns 75% of the total equity in of Novartis India. In 2013, it offloaded... Read more
2d
Business Wire
Technavio Announces Top Six Vendors in the Global Pneumatic Nebulizers Market from 2016 to 2020than 20 clinical trials of new medications. The company also supplies its nebul
Technavio Announces Top Six Vendors in the Global Pneumatic Nebulizers Market from 2016 to 2020
Business Wire / Posted 2 days ago
than 20 clinical trials of new medications. The company also supplies its nebulizers to pharmaceutical companies such as Novartis and AstraZeneca for them to supply aerosol-based drugs. It has developed or is in the process of producing products... Read more
2d
Swissinfo
Loopholes persist amid lethal drug export bansnearly two dozen pharmaceutical companies have announced similar policies in th
Loopholes persist amid lethal drug export bans
Swissinfo / Posted 2 days ago
nearly two dozen pharmaceutical companies have announced similar policies in the last five years. Swiss drug makers Novartis and Roche had produced painkillers and sedatives used in the lethal drug cocktail but eventually joined the movement... Read more
2d
Boston Globe
Agios targets immuno-oncology after Celgene dealmajority of patients.” Agios chief scientific officer Scott Biller, the former
Agios targets immuno-oncology after Celgene deal
Boston Globe / Posted 2 days ago
majority of patients.” Agios chief scientific officer Scott Biller, the former head of global discovery chemistry at the Novartis Institutes for Biomedical Research, said Agios scientists are looking into the metabolism of the immune system. “The... Read more
2d
Business Wire
Cell Medica Expands Management Team with Experienced Pharmaceutical Executivesindustry. Prior to joining Cell Medica, Dr. Müller held various commercial posi
Cell Medica Expands Management Team with Experienced Pharmaceutical Executives
Business Wire / Posted 2 days ago
industry. Prior to joining Cell Medica, Dr. Müller held various commercial positions of increasing responsibility at Novartis mainly in the area of specialty drugs. Earlier in his career, he was a consultant at Bain & Company, a leading... Read more
2d
Business Standard India
Markets snap 4-day losing streak; European cues supportcompany reported 32% year-on-year (YoY) decline in net profit at Rs 13.21 crore
Markets snap 4-day losing streak; European cues support
Business Standard India / Posted 2 days ago
company reported 32% year-on-year (YoY) decline in net profit at Rs 13.21 crore for the quarter ended March 2016 (Q4FY16). Novartis India surged 17% after the pharmaceutical company announced that its board will meet on Thursday, May 26, 2016, to... Read more
14 related stories
2d
Business Standard India
Markets turn flat; Nifty below 7,750company reported 32% year-on-year (YoY) decline in net profit at Rs 13.21 crore
Markets turn flat; Nifty below 7,750
Business Standard India / Posted 2 days ago
company reported 32% year-on-year (YoY) decline in net profit at Rs 13.21 crore for the quarter ended March 2016 (Q4FY16). Novartis India has surged 16% after the pharmaceutical company announced that its board will meet on Thursday, May 26, 2016,... Read more
14 related stories
2d
Business Standard India
Novartis India surges on share buyback plansThe stock surged 15% to Rs 818 on the BSE in early morning trade. Novartis Ind
Novartis India surges on share buyback plans
Business Standard India / Posted 2 days ago
The stock surged 15% to Rs 818 on the BSE in early morning trade. Novartis India has surged 15% to Rs 818 on the BSE in early morning trade after the pharmaceutical company announced that its board will... Read more
2d
Business Standard India
Markets remain rangebound; Cipla up 1% ahead of Q4 resultscontract from Commerzbank, the second largest bank in Germany. Shares of Infosy
Markets remain rangebound; Cipla up 1% ahead of Q4 results
Business Standard India / Posted 2 days ago
contract from Commerzbank, the second largest bank in Germany. Shares of Infosys are down 0.4%. Among other shares, Novartis India has surged 15% to Rs 818 on the BSE in early morning trade after the pharmaceutical company announced that its... Read more
14 related stories
2d
The Economic Times
Twelve stocks in focus in Tuesday morning tradecompany on Monday reported a 27.14 per cent decline in net profit at Rs 265.59
Twelve stocks in focus in Tuesday morning trade
The Economic Times / Posted 2 days ago
company on Monday reported a 27.14 per cent decline in net profit at Rs 265.59 crore for the quarter ended March 31, 2016. Novartis India Ltd: Novartis has announced that its Board will consider a proposal for Buyback of the Company's equity shares... Read more
157 related stories
3d
The Young Witness
Shooting for seven-week winning streakis always something to panic about, but underneath, things are kind of OK." Eu
Shooting for seven-week winning streak
The Young Witness / Posted 3 days ago
is always something to panic about, but underneath, things are kind of OK." European shares rose the most in a month. Novartis climbed 1.8 per cent after the UK affirmed its backing of a cancer treatment, helping a measure of health companies... Read more
31 related stories
3d
Manning River Times
Shooting for seven-week winning streakis always something to panic about, but underneath, things are kind of OK." Eu
Shooting for seven-week winning streak
Manning River Times / Posted 3 days ago
is always something to panic about, but underneath, things are kind of OK." European shares rose the most in a month. Novartis climbed 1.8 per cent after the UK affirmed its backing of a cancer treatment, helping a measure of health companies... Read more
31 related stories
3d
KERA North Texas
Inventing A Machine That Spits Out Drugs In A Whole New Wayus with a lot of opportunities that are very powerful," says Jamison. His lab a
Inventing A Machine That Spits Out Drugs In A Whole New Way
KERA North Texas / Posted 3 days ago
us with a lot of opportunities that are very powerful," says Jamison. His lab and Myerson's also are collaborating with the Novartis- MIT Center for Continuous Manufacturing, which is funded by the pharmaceutical company Novartis. The prototype... Read more
3d
KPBS San Diego
Inventing A Machine That Spits Out Drugs In A Whole New Wayus with a lot of opportunities that are very powerful," says Jamison. His lab a
Inventing A Machine That Spits Out Drugs In A Whole New Way
KPBS San Diego / Posted 3 days ago
us with a lot of opportunities that are very powerful," says Jamison. His lab and Myerson's also are collaborating with the Novartis- MIT Center for Continuous Manufacturing, which is funded by the pharmaceutical company Novartis. The prototype... Read more
3d
Channel NewsAsia
Novartis executive exodus complicates drugmaker's rebuilding jobZURICH: With seven departures in the space of five months, Novartis's top manag
Novartis executive exodus complicates drugmaker's rebuilding job
Channel NewsAsia / Posted 3 days ago
ZURICH: With seven departures in the space of five months, Novartis's top management is in upheaval just as CEO Joe Jimenez tries to tackle a list of challenges that have seen the drug firm's share price fall 25 percent since July. The most dramatic... Read more
3d
Reuters
Novartis executive exodus complicates drugmaker's rebuilding jobZURICH With seven departures in the space of five months, Novartis's (NOVN.S) t
Novartis executive exodus complicates drugmaker's rebuilding job
Reuters / Posted 3 days ago
ZURICH With seven departures in the space of five months, Novartis's (NOVN.S) top management is in upheaval just as CEO Joe Jimenez tries to tackle a list of challenges that have seen the drug firm's share price fall 25 percent since July. The most... Read more
3d
Business Wire
Nordic Nanovector ASA: New Board Members Elected Bringing Further Expertise in the Development and Commercialization of Innovative Cancer Therapiesalso has extensive life sciences consulting and advisory experience as well as
Nordic Nanovector ASA: New Board Members Elected Bringing Further Expertise in the Development and Commercialization of Innovative Cancer Therapies
Business Wire / Posted 3 days ago
also has extensive life sciences consulting and advisory experience as well as leadership experience from companies such as Novartis, Bristol Myers Squibb and Merck. She holds a Bachelor of Science degree in Pharmacy from the University of... Read more
4d
Brisbane Times
Shooting for seven-week winning streakis always something to panic about, but underneath, things are kind of OK." Eu
Shooting for seven-week winning streak
Brisbane Times / Posted 4 days ago
is always something to panic about, but underneath, things are kind of OK." European shares rose the most in a month. Novartis climbed 1.8 per cent after the UK affirmed its backing of a cancer treatment, helping a measure of health companies... Read more
31 related stories
4d
WA Today
Shooting for seven-week winning streakis always something to panic about, but underneath, things are kind of OK." Eu
Shooting for seven-week winning streak
WA Today / Posted 4 days ago
is always something to panic about, but underneath, things are kind of OK." European shares rose the most in a month. Novartis climbed 1.8 per cent after the UK affirmed its backing of a cancer treatment, helping a measure of health companies... Read more
31 related stories
4d
The Age
Shooting for seven-week winning streakis always something to panic about, but underneath, things are kind of OK." Eu
Shooting for seven-week winning streak
The Age / Posted 4 days ago
is always something to panic about, but underneath, things are kind of OK." European shares rose the most in a month. Novartis climbed 1.8 per cent after the UK affirmed its backing of a cancer treatment, helping a measure of health companies... Read more
31 related stories
4d
Sydney Morning Herald
Shooting for seven-week winning streakis always something to panic about, but underneath, things are kind of OK." Eu
Shooting for seven-week winning streak
Sydney Morning Herald / Posted 4 days ago
is always something to panic about, but underneath, things are kind of OK." European shares rose the most in a month. Novartis climbed 1.8 per cent after the UK affirmed its backing of a cancer treatment, helping a measure of health companies... Read more
31 related stories
4d
Canberra Times
Shooting for seven-week winning streakis always something to panic about, but underneath, things are kind of OK." Eu
Shooting for seven-week winning streak
Canberra Times / Posted 4 days ago
is always something to panic about, but underneath, things are kind of OK." European shares rose the most in a month. Novartis climbed 1.8 per cent after the UK affirmed its backing of a cancer treatment, helping a measure of health companies... Read more
31 related stories
4d
Daily Record
Gannon surpasses Sierchio in funds raised, spent for Morris sheriff racecounty Prosecutor's Office, and upon retirement from there, was global head of
Gannon surpasses Sierchio in funds raised, spent for Morris sheriff race
Daily Record / Posted 4 days ago
county Prosecutor's Office, and upon retirement from there, was global head of security risk for the pharmaceutical company Novartis. They both got a $1,000 donation from the International Brotherhood of Electrical Workers, Local 102 in Parsippany.... Read more
4d
Philly.com
Cancer breakthrough? New 'Universal' T-cell therapy draws praise, doubtin 2010, but it was costly and barely effective against prostate cancer. In 201
Cancer breakthrough? New 'Universal' T-cell therapy draws praise, doubt
Philly.com / Posted 4 days ago
in 2010, but it was costly and barely effective against prostate cancer. In 2012, Dendreon sold its production plant to Novartis, which is commercializing Penn's T-cell therapy. Dendreon declared bankruptcy in 2014. "Dendreon's example shows... Read more
5d
Fortune
Struggling Novartis Heart Drug Boosted by New Medical GuidelinesNew global guidelines on the treatment of heart failure strongly endorse the us
Struggling Novartis Heart Drug Boosted by New Medical Guidelines
Fortune / Posted 5 days ago
New global guidelines on the treatment of heart failure strongly endorse the use of Novartis’ Entresto, boosting the prospects for a drug that has struggled to gain traction since its launch last year. U.S. and European heart experts gave the... Read more
2 related stories
5d
Channel NewsAsia
Struggling Novartis heart drug boosted by new medical guidelinesLONDON: New global guidelines on the treatment of heart failure strongly endors
Struggling Novartis heart drug boosted by new medical guidelines
Channel NewsAsia / Posted 5 days ago
LONDON: New global guidelines on the treatment of heart failure strongly endorse the use of Novartis' Entresto, boosting the prospects for a drug that has struggled to gain traction since its launch last year. U.S. and European heart experts gave... Read more
2 related stories
5d
The Financial Express
High Court seeks Centre’s response on plea for ban on painkiller jabThe Delhi High Court on Friday sought response from the Centre, Novartis India
High Court seeks Centre’s response on plea for ban on painkiller jab
The Financial Express / Posted 5 days ago
The Delhi High Court on Friday sought response from the Centre, Novartis India and others on a petition by Gujarat-based Troikaa Pharmaceuticals Ltd asking the Drug Controller General of India (DCGI) to stop sales and cancel licence of popular... Read more
6d
Channel NewsAsia
New medical guidelines back use of Novartis heart failure drugLONDON: New global guidelines on the treatment of heart failure endorse the use
New medical guidelines back use of Novartis heart failure drug
Channel NewsAsia / Posted 6 days ago
LONDON: New global guidelines on the treatment of heart failure endorse the use of Novartis' Entresto, boosting the prospects for a drug that has struggled to gain traction since its launch last year. U.S. and European heart experts said on Friday... Read more
2 related stories
6d
The Irish Times
Shares rally to reverse losing streakThe company said that trading conditions in the period continued to be challeng
Shares rally to reverse losing streak
The Irish Times / Posted 6 days ago
The company said that trading conditions in the period continued to be challenging, and reiterated its 2016 outlook.Europe Novartis climbed 1.8 per cent after the UK affirmed its backing of a cancer treatment, helping a measure of health companies... Read more
7d
The Huffington Post
Dear Senator: Do You Really Want Cancer Drugs To Be Super-Expensive?first published by the nonprofit group Knowledge Ecology International more tha
Dear Senator: Do You Really Want Cancer Drugs To Be Super-Expensive?
The Huffington Post / Posted 7 days ago
first published by the nonprofit group Knowledge Ecology International more than a week ago. Swiss pharmaceutical giant Novartis currently charges nearly double Colombia’s per-capita income to provide a single patient with a one-year supply of... Read more
22 related stories
7d
FOX Business
Will These Game-Changing Cancer Treatments Hit the Market in 2016?cancers that have few, if any, treatment options at the moment. As it stands n
Will These Game-Changing Cancer Treatments Hit the Market in 2016?
FOX Business / Posted 7 days ago
cancers that have few, if any, treatment options at the moment. As it stands now, Kite Pharma , Juno Therapeutics , and Novartis are leading the race to bring the first FDA-approved CAR T cell therapy to market. Specifically, Kite is on track... Read more
3 related stories
7d
FOX Business
Will These Game-Changing Cancer Treatments Hit the Market in 2016?cancers that have few, if any, treatment options at the moment. As it stands n
Will These Game-Changing Cancer Treatments Hit the Market in 2016?
FOX Business / Posted 7 days ago
cancers that have few, if any, treatment options at the moment. As it stands now, Kite Pharma , Juno Therapeutics , and Novartis are leading the race to bring the first FDA-approved CAR T cell therapy to market. Specifically, Kite is on track... Read more
3 related stories
7d
Quartz
Bayer is wooing Monsanto for a possible mega-mergeremployees. To be sure, Bayer and Monsanto could pursue other agreements if a f
Bayer is wooing Monsanto for a possible mega-merger
Quartz / Posted 7 days ago
employees. To be sure, Bayer and Monsanto could pursue other agreements if a full acquisition doesn’t pan out. That could include asset swaps (akin to the $20 billion GlaxoSmithKline-Novartis swap in 2015) or even a joint venture.Read fu... Read more
7d
The Economic Times
Indian pharma company may sue drug controller over safety of Novartis painkillersue the government for not putting an end to sales of a popular painkiller inje
Indian pharma company may sue drug controller over safety of Novartis painkiller
The Economic Times / Posted 7 days ago
sue the government for not putting an end to sales of a popular painkiller injection marketed by multinational drug maker Novartis India . Troikaa alleges that the painkiller contains an ingredient that may compromise patient safety because it is... Read more
7d
Channel NewsAsia
Novartis launches new Entresto trials in bid to boost salesZURICH: Novartis's heart failure drug Entresto will be subjected to a battery o
Novartis launches new Entresto trials in bid to boost sales
Channel NewsAsia / Posted 7 days ago
ZURICH: Novartis's heart failure drug Entresto will be subjected to a battery of new trials as the Swiss drugmaker seeks to boost the medicine after a disappointing introduction. Novartis, which on Thursday described the trials as "the largest... Read more
7d
NJ Biz
Novartis revamps pharma business, but with little effect on N.J. operationsThe shakeup at Novartis is unlikely to have any major effect on the drugmaker's
Novartis revamps pharma business, but with little effect on N.J. operations
NJ Biz / Posted 7 days ago
The shakeup at Novartis is unlikely to have any major effect on the drugmaker's operations in New Jersey, a company representative told NJBIZ. Earlier this week, Novartis announced it would restructure its pharmaceuticals division effective July 1... Read more
7d
Business Wire
Magyar Telecom B.V. Announces Financial Results for the Quarter Ended March 31, 2016, and Appointment of CFOHis career has included headquarters, regional and country assignments in six c
Magyar Telecom B.V. Announces Financial Results for the Quarter Ended March 31, 2016, and Appointment of CFO
Business Wire / Posted 7 days ago
His career has included headquarters, regional and country assignments in six countries with companies such as Sandoz/Novartis, Philip Morris International and GE. Prior to joining Invitel, Mr. Balogh served as regional CFO for two firms in... Read more
7d
dna
India proposes oil-for-drugs deal with Venezuela to recoup pharma duesMost of that was pharmaceutical products.Social Unrest The amount owed to Indi
India proposes oil-for-drugs deal with Venezuela to recoup pharma dues
dna / Posted 7 days ago
Most of that was pharmaceutical products.Social Unrest The amount owed to Indian companies is modest on a global scale - Novartis AG, Bayer AG and Sanofi SA took heavier hits when they agreed to take bonds from state-owned oil company PDVSA in... Read more
6 related stories
8d
The Signal
Colombia battles world's biggest drugmaker over cancer drugally, from the pharmaceutical industry and its allies in the U.S. Congress. In
Colombia battles world's biggest drugmaker over cancer drug
The Signal / Posted 8 days ago
ally, from the pharmaceutical industry and its allies in the U.S. Congress. In one memo, the embassy warns that breaking Novartis' patent for the leukemia drug Gleevec could hurt U.S. support for Colombia's bid to join the proposed Trans-Pacific... Read more
22 related stories
8d
The Hamilton Journal News
Colombia battles world's biggest drugmaker over cancer drugColombia's government is giving pharmaceutical giant Novartis a few weeks to lo
Colombia battles world's biggest drugmaker over cancer drug
The Hamilton Journal News / Posted 8 days ago
Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals. Health Minister Alejandro... Read more
22 related stories
More

People in this news